Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tsukagoshi

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 1, 1998
[Development of new anticancer drugs--the historical background and current status in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Antitumor candidate compounds under clinical trials in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Advance in cancer chemotherapy]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 9, 1999
[Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1993
[A new antileukemic drug, cytarabine ocfosfate]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
[Problems in the development of analogs of anticancer drugs]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1985
[Experimental studies with the use of metastatic clones isolated from mouse tumors]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1997
[Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[A novel antitumor agent, sobuzoxane (MST-16)]S Tsukagoshi
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 1, 1998
[Development of new anticancer drugs--the historical background and current status in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1990
[Antitumor candidate compounds under clinical trials in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Advance in cancer chemotherapy]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 9, 1999
[Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1993
[A new antileukemic drug, cytarabine ocfosfate]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
[Problems in the development of analogs of anticancer drugs]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1985
[Experimental studies with the use of metastatic clones isolated from mouse tumors]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1997
[Development of a new tubulin-interacting agent, docetaxel (taxotere) in Japan]S Tsukagoshi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1994
[A novel antitumor agent, sobuzoxane (MST-16)]S Tsukagoshi
Pageof 18